Christine Cotton - Biostatisticienne - Lanceuse d'alerte

Key statements

• Trial-participant adverse events are missing or not reported: Maddie de Garay (US, Pfizer 12-15 trial, 35 serious events) and Augusto Roux (Argentina, Pfizer adult trial, nearly died) called Cotton directly; neither appears properly in the trial database. ▶ 07:24
  Sources: Augusto Roux medical file; Maddie de Garay testimony to Sen. Ron Johnson
• Cotton's January 2022 expertise frames the Pfizer trial against ICH Good Clinical Practice — if data are not valid, results are not valid; if the primary endpoint is wrongly chosen, the demonstrated efficacy is false. Transmission was not studied, asymptomatic cases were not studied, and there was no demonstrated effect on severe cases. ▶ 09:29
  Sources: Cotton — Expertise of the Pfizer C4591001 trial (January 2022); ICH-GCP guidelines
• Pfizer also collected anti-nucleocapsid serology — the marker that catches anyone who actually had COVID during the trial — but never published the analysis. Computed on the court-released database, Cotton finds about 55% efficacy on this marker, versus the published 95% on PCR-confirmed symptomatic cases. ▶ 12:46
  Sources: Pfizer C4591001 court-released trial database (PHMPT / FOIA)
• France's HAS (Haute Autorité de Santé) noted, in writing, in December 2020 that Pfizer was already studying a booster — proving they knew protection would not last when the original two-dose regimen was sold to the public. ▶ 17:45
  Sources: HAS opinion on Comirnaty (December 2020)
• Cotton's VAERS analysis (more than 400,000 lines) found over 60% of vaccine-associated deaths occurred within 21 days of injection. Reading the individual death reports, she encountered grandparents found dead the next morning and young people dying at their desks during math class. ▶ 22:24
  Sources: VAERS public dataset (US adverse-event reports)
• The EU Risk Management Plan formally records, since December 2020, that pregnant women are not included in the trial and that autoimmune-disease patients have not been tested. Pregnant women were then classified as a high-risk population and prioritized for vaccination. ▶ 23:21
  Sources: Comirnaty Risk Management Plan (December 2020, EMA)
• An FDA presentation in October 2020 listed expected adverse events including neurological and blood disorders — but did not anticipate menstrual disturbances, which today account for a substantial share of the EU adverse-event database. ▶ 31:09
  Sources: FDA VRBPAC meeting (Oct 2020) — adverse-events-to-monitor slides
• Of 77 trial pregnancies, Cotton finds more miscarriages in the placebo arm than in the vaccine arm — which she reads as evidence that the trial data are unreliable, given the known under-reporting of serious events such as the Augusto Roux and Maddie de Garay cases. ▶ 34:35
  Sources: Pfizer C4591001 court-released trial database (PHMPT / FOIA)
• In France, a criminal complaint for poisoning has been filed. Cotton helped re-read the complaint and drafted the sections covering her expertise report — arguing that if the registration trial is fraudulent, manufacturers, not the state, should bear the cost of adverse-event compensation. ▶ 39:51
  Sources: French criminal complaint for poisoning (2022); Cotton — Expertise of the Pfizer C4591001 trial (January 2022)
• After Cotton posted her January 2022 expertise on LinkedIn, the post was visited within two days — before LinkedIn closed her account — by 133 lawyers, plus visitors from Apple, the US State Department, the WHO, and others. ▶ 40:50
  Sources: Cotton — January 2022 expertise report (LinkedIn post, screenshots)

Documents cited

• Pfizer C4591001 interim clinical study report (December 2020) — FDA briefing documents, Dec 2020 VRBPAC
• Pfizer C4591001 court-released trial database (XPT / SAS) — PHMPT / FOIA disclosures (phmpt.org)
• Comirnaty Risk Management Plan (December 2020, EMA) — EMA EPAR archive
• VAERS public dataset (US adverse-event reports) — openvaers.com / CDC WONDER
• HAS opinion on Comirnaty (December 2020) — has-sante.fr archive
• FDA VRBPAC meeting (October 2020) — adverse-events-to-monitor slides — FDA / CDC public materials
• Cotton — Expertise of the Pfizer C4591001 trial (January 2022) — christinecotton.com
• Maddie de Garay testimony (Sen. Ron Johnson press conference) — Sen. Ron Johnson public events
• Augusto Roux medical file (Argentine trial participant) — Personal records, cited in legal filings

• Retrieve the December 2020 HAS opinion on Comirnaty and quote the exact sentence acknowledging Pfizer was already studying a booster. Add the source page to catalog/external_links.html.Cited at ~17:45 as the smoking-gun proof regulators knew about waning protection at the moment of authorization.

  Sources she cites in the book

  • 134 Haute Autorité de Santé (HAS) — opinion/report on the COVID-19 vaccination strategy and the place of the mRNA vaccine Comirnaty (BNT162b2), December 2020 ⧉ archived
  • 135 Pfizer/FDA — BNT162b2 Module 1.6.3 Correspondence Regarding Meetings (released via PHMPT FOIA), Oct 2023 ⧉ archived
  • 130 FDA — 'Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry' (Immunogenicity criteria chapter) ⧉ archived
  • 131 Pfizer — Clinical report (Dec 10, 2020), Phase 1/2 immunogenicity results, neutralizing antibody geometric means, 18-55 years (FDA-hosted)
• Find Cotton's VAERS analysis Substack / report (the one establishing the 60% deaths-within-21-days figure across ~400,000 reports) and archive it.Referenced at ~20:39 / ~22:24 as the work that pushed her back to dissecting the Pfizer trial.

  Sources she cites in the book

  • 37 FranceSoir — 'Les Débriefings' video: alert on VAERS data, 67% of registered deaths occur within 21 days (Cotton's August 2021 presentation of her VAERS analysis)
  • 35 VAERS — Vaccine Adverse Event Reporting System (co-managed by CDC and FDA), public dataset
  • 36 SAS Institute — SAS (Statistical Analysis System) software, health care page
  • 38 Jonville-Béra (Head of French Pharmacovigilance Centers) — 2006 article on vaccine adverse events (PubMed)
• Add the French criminal complaint for poisoning (with the section drawn from Cotton's expertise report) to archive/sources/ once a public copy is available — or note the case reference if redacted.Cited at ~39:51 as the legal mechanism by which the GCP critique could reverse liability from states to manufacturers.

  Sources she cites in the book

  • French criminal complaint against 'unknown parties' for poisoning, filed by several victims as of May 2022 (no public copy or case reference given in the book)
• Archive the LinkedIn-page screenshots showing the 133 lawyers and the institutional visitors (Apple, US State Department, WHO, etc.) to Cotton's January 2022 post — kept locally, used in `notes` to substantiate the regulatory-pressure claim.Cited at ~40:50. Cotton confirms she kept the print-screens before LinkedIn shut her account.